The Blackstone Group
Industry Snippets: Private equity giant Blackstone buys Clarus in biopharma push - Fierce biotech
The Blackstone Group

Blackstone has struck a deal to buy Clarus. The takeover will move private equity giant Blackstone deeper into biopharma, where it plans to use its financial might to fund R&D programs that have outgrown the means of traditional venture capital firms. 

Full article on Fierce Biotech can be found here